Howard JJ, Utsugisawa K, Benatar M, et al. Safety and efficacy of eculizumab in anti -acetylcholine receptor antibody -positive refractory ulticenter myasthenia gravis (REGAIN): a phase 3, ulticente, double -blind, placebo -controlled, ulticenter study [J]. Lancet Neurology, 2017,16(12):976-986.
Beecher G, Anderson D, Siddiqi ZA. Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial[J].Neurology,2017,89(11):1135-1141.